Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua Chen

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Prostate Cancer and Prostatic Diseases|December 6, 2023
Prostein expression on circulating tumor cells as a prognostic marker in metastatic castration-resistant prostate cancerZhenchao Zhang, Rui Luo, William K Kelly, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2023
Preclinical Evaluation of the ATR Inhibitor BAY 1895344 as a Radiosensitizer for Head and Neck Squamous Cell CarcinomaDiana A Odhiambo, Allison N Pittman, Ashlyn G Rickard, et al.
Annals of the New York Academy of Sciences|March 26, 2011
Raltegravir: the first HIV-1 integrase strand transfer inhibitor in the HIV armamentariumBach-Yen T Nguyen, Robin D Isaacs, Hedy Teppler, et al.
The New England Journal of Medicine|February 19, 2015
A 9-valent HPV vaccine against infection and intraepithelial neoplasia in womenElmar A Joura, Anna R Giuliano, Ole-Erik Iversen, et al.
The New England Journal of Medicine|July 25, 2008
Raltegravir with optimized background therapy for resistant HIV-1 infectionRoy T Steigbigel, David A Cooper, Princy N Kumar, et al.
The New England Journal of Medicine|July 25, 2008
Subgroup and resistance analyses of raltegravir for resistant HIV-1 infectionDavid A Cooper, Roy T Steigbigel, Jose M Gatell, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Prostate Cancer and Prostatic Diseases|December 6, 2023
Prostein expression on circulating tumor cells as a prognostic marker in metastatic castration-resistant prostate cancerZhenchao Zhang, Rui Luo, William K Kelly, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2023
Preclinical Evaluation of the ATR Inhibitor BAY 1895344 as a Radiosensitizer for Head and Neck Squamous Cell CarcinomaDiana A Odhiambo, Allison N Pittman, Ashlyn G Rickard, et al.
Annals of the New York Academy of Sciences|March 26, 2011
Raltegravir: the first HIV-1 integrase strand transfer inhibitor in the HIV armamentariumBach-Yen T Nguyen, Robin D Isaacs, Hedy Teppler, et al.
The New England Journal of Medicine|February 19, 2015
A 9-valent HPV vaccine against infection and intraepithelial neoplasia in womenElmar A Joura, Anna R Giuliano, Ole-Erik Iversen, et al.
The New England Journal of Medicine|July 25, 2008
Raltegravir with optimized background therapy for resistant HIV-1 infectionRoy T Steigbigel, David A Cooper, Princy N Kumar, et al.
The New England Journal of Medicine|July 25, 2008
Subgroup and resistance analyses of raltegravir for resistant HIV-1 infectionDavid A Cooper, Roy T Steigbigel, Jose M Gatell, et al.
Pageof 7